Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Watschinger

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2021
Assessment of pre-donation glomerular filtration rate: going back to basicsChristophe Mariat, Geir Mjøen, Bruno Watschinger, et al.
Transplant Immunology|December 2, 2006
Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipientsBernhard M Kirsch, Michael Haidinger, Maximilian Zeyda, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2002
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injuryGeorg A Böhmig, Markus Exner, Antje Habicht, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2019
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysisAnna Pisano, Davide Bolignano, Francesca Mallamaci, et al.
Journal of Leukocyte Biology|October 14, 2006
Impairment of T cell interactions with antigen-presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF-kappaB in immunological synapse formationMaximilian Zeyda, René Geyeregger, Marko Poglitsch, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2022
Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working GroupIlaria Gandolfini, Marta Crespo, Rachel Hellemans, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 24, 2015
Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case-match analysisChristoph Schwarz, Sophie Mayerhoffer, Gabriela A Berlakovich, et al.
Arthritis Research & Therapy|May 19, 2005
The active metabolite of leflunomide, A77 1726, interferes with dendritic cell functionBernhard M Kirsch, Maximilian Zeyda, Karl Stuhlmeier, et al.
Wiener Klinische Wochenschrift|November 28, 2012
Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012Thomas Weber, Robert Zweiker, Bruno Watschinger, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2025
The factor XIa antibody osocimab strongly inhibits clotting in extracorporeal circuits with human blood and in baboonsEslam Samaha, Michael Schwameis, Sabine Schranz, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2021
Assessment of pre-donation glomerular filtration rate: going back to basicsChristophe Mariat, Geir Mjøen, Bruno Watschinger, et al.
Transplant Immunology|December 2, 2006
Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipientsBernhard M Kirsch, Michael Haidinger, Maximilian Zeyda, et al.
Journal of the American Society of Nephrology : JASN|March 26, 2002
Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injuryGeorg A Böhmig, Markus Exner, Antje Habicht, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2019
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysisAnna Pisano, Davide Bolignano, Francesca Mallamaci, et al.
Journal of Leukocyte Biology|October 14, 2006
Impairment of T cell interactions with antigen-presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF-kappaB in immunological synapse formationMaximilian Zeyda, René Geyeregger, Marko Poglitsch, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2022
Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working GroupIlaria Gandolfini, Marta Crespo, Rachel Hellemans, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 24, 2015
Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case-match analysisChristoph Schwarz, Sophie Mayerhoffer, Gabriela A Berlakovich, et al.
Arthritis Research & Therapy|May 19, 2005
The active metabolite of leflunomide, A77 1726, interferes with dendritic cell functionBernhard M Kirsch, Maximilian Zeyda, Karl Stuhlmeier, et al.
Wiener Klinische Wochenschrift|November 28, 2012
Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012Thomas Weber, Robert Zweiker, Bruno Watschinger, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2025
The factor XIa antibody osocimab strongly inhibits clotting in extracorporeal circuits with human blood and in baboonsEslam Samaha, Michael Schwameis, Sabine Schranz, et al.
Pageof 7